Gigantol ameliorates CCl4-induced liver injury via preventing activation of JNK/cPLA2/12-LOX inflammatory pathway
文献类型:期刊论文
作者 | Xue, Yaru4,5; Deng, Qiangqiang4; Zhang, Qingli6; Ma, Zhenghua1,2,3; Chen, Binfan4,5; Yu, Xiaolu4,5; Peng, Huige4; Yao, Sheng2,3,4; Liu, Jia6; Ye, Yang1,2,3,4 |
刊名 | SCIENTIFIC REPORTS |
出版日期 | 2020-12-17 |
卷号 | 10期号:1页码:13 |
ISSN号 | 2045-2322 |
DOI | 10.1038/s41598-020-79400-0 |
通讯作者 | Ye, Yang(yye@simm.ac.cn) ; Pan, Guoyu(gypan@simm.ac.cn) |
英文摘要 | Arachidonic acid (AA) signaling pathway is an important constituent of inflammatory processes. In our previous study, it was found that dihydro-stilbene gigantol relieved hepatic inflammation in mice with CCl4-induced acute liver injury. This study aimed to investigate the involvement of arachidonate metabolic cascade in this process. Our results showed CCl4 activated AA metabolism with the evidence of cPLA2 phosphorylation, which was dependent on the MAPK/JNK activation. Pretreatment with JNK inhibitor SU3327 or gigantol abolished the cPLA2 activation, along with the attenuation of liver damage. Besides, gigantol markedly decreased immune cells activation. Metabolomic analysis revealed that gigantol universally reversed the upregulation of major AA metabolites in injured mouse livers induced by CCl4, especially 12-hydroxyeicosatetraenoic acid (12-HETE). Gigantol also decreased the mRNA and protein expression of platelet-, and leukocyte-type 12-lipoxxygenase (LOX) in the liver. Furthermore, pan-LOX inhibitor nordihydroguaiaretic acid (NDGA) and specific 12-LOX inhibitors baicalein and ML351 attenuated the liver injury to the same extent as gigantol. Overall, our study elucidated a comprehensive profile of AA metabolites during hepatic inflammation caused by CCl4, highlighting the role of 12-LOX-12-HETE pathway in this process. And gigantol alleviated liver inflammation partly through inhibiting the JNK/cPLA2/12-LOX pathway. |
WOS关键词 | ARACHIDONIC-ACID ; CARBON-TETRACHLORIDE ; 12/15-LIPOXYGENASE ; INHIBITION ; DYSFUNCTION ; 15-HUMAN ; 12-HUMAN ; MODELS ; POTENT ; CELLS |
资助项目 | Chinese Academy of Sciences[XDA16020205] ; National Science Foundation of China[81872927] ; International Partnership Program of Chinese Academy of Sciences[153631KYSB20160004] ; Independent Deployment Program of the Institute of Pharmaceutical Innovation of the Chinese Academy of Sciences[CASIMM0120184005] ; China Postdoctoral Science Foundation[2019M651623] |
WOS研究方向 | Science & Technology - Other Topics |
语种 | 英语 |
出版者 | NATURE RESEARCH |
WOS记录号 | WOS:000603258300074 |
源URL | [http://119.78.100.183/handle/2S10ELR8/296064] |
专题 | 新药研究国家重点实验室 |
通讯作者 | Ye, Yang; Pan, Guoyu |
作者单位 | 1.Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 201203, Peoples R China 2.Chinese Acad Sci, Inst Mat Med, State Key Lab Drug Res & Nat Prod, Chem Dept Shanghai, Shanghai 201203, Peoples R China 3.SIMM CUHK Joint Res Lab Promoting Globalizat Trad, Shanghai 201203, Peoples R China 4.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China 5.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 6.Chinese Acad Sci, Inst Technol Serv Ctr, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Xue, Yaru,Deng, Qiangqiang,Zhang, Qingli,et al. Gigantol ameliorates CCl4-induced liver injury via preventing activation of JNK/cPLA2/12-LOX inflammatory pathway[J]. SCIENTIFIC REPORTS,2020,10(1):13. |
APA | Xue, Yaru.,Deng, Qiangqiang.,Zhang, Qingli.,Ma, Zhenghua.,Chen, Binfan.,...&Pan, Guoyu.(2020).Gigantol ameliorates CCl4-induced liver injury via preventing activation of JNK/cPLA2/12-LOX inflammatory pathway.SCIENTIFIC REPORTS,10(1),13. |
MLA | Xue, Yaru,et al."Gigantol ameliorates CCl4-induced liver injury via preventing activation of JNK/cPLA2/12-LOX inflammatory pathway".SCIENTIFIC REPORTS 10.1(2020):13. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。